Skip to content

Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules

Safety and Feasibility of a Novel Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04211051
Enrollment
10
Registered
2019-12-26
Start date
2020-04-15
Completion date
2020-10-21
Last updated
2021-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms

Keywords

lung neoplasm, localization of lung nodules, ground glass opacity

Brief summary

As the detection of small pulmonary nodules continuously grows, the intraoperative localization of small pulmonary nodules is in great demand. The intraoperative localization nowadays is usually done under local anesthesia before surgery. There is a certain rate of failure and complication. The result of our early animal experiments show that the pulmonary surgery marker system can deliver the intraoperative localization safely and precisely under anesthesia, and the average distance between the localization and the simulated lesion is less than 5mm during surgery. Therefore, the safety and feasibility of the system require further evaluation in patients

Detailed description

This is a prospective, single-center clinical trial initiated by the investigator. LungBrella marker can be accurately implanted into a predetermined position in the lung assisted by JediVision software and successfully marked the pulmonary nodules which needs to undergo Video-assisted thoracoscopic surgery. The study is expected to enroll 10 patients. Finally, the effectiveness and safety of the method will be evaluated. This method not only can complete pulmonary nodule localization in the operating room without occupying the resources of radiology department, but also can let patients receive pulmonary nodule location after anesthesia. Thereby the risks during transportation are avoided and the suffering of patients is reduced.

Interventions

The enrolled patients will receive a plain chest CT scan,then the data be loaded into JediVision software. The JediVision software can navigate the location of nodule and facilitate the implantation of LungBrella marker in the operating room after general anesthesia,then the patients will receive VATS partial lobe resection .

Sponsors

Shanghai Futuo Zhida Medical Technology Co., Ltd
CollaboratorUNKNOWN
Ruijin Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Subjects should meet all of the following criteria * diagnosis of pulmonary nodule, single nodule operation to be performed and nodule to be located by the decision of chief surgeon. * commit to follow the research procedures and cooperate with the implementation of the whole process research * 1 / 3 of pulmonary nodules are located in the periphery of the lung * signed informed consent with date

Exclusion criteria

* the target lesion is close to the hilar or large blood vessels * subjects with FEV1 less than 1.2 in lung function * subjects with cardiac function III and cardiac function IV (NYHA, New York) * subjects with uncontrollable acute pleura infection * patients with previous history of thoracic surgery (thoracotomy), plural infection, and plural thickening and adhesion on the affected side * Other factors that investigators disagree enrollment.

Design outcomes

Primary

MeasureTime frameDescription
Positioning success rateImmediately after resectionWhen the distance between the LungBrella marker and the Pulmonary nodule is less than 10mm, the marker position is successful. The success rate is the proportion of successful cases to all operation cases

Secondary

MeasureTime frameDescription
Procedure timeDuration of procedureCollect total procedure time for lung localization and surgical resection.
ComplicationsOne monthProcedure-related complications will be recorded.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026